Перлович Герман Леонидович

2017 – 2019

1. Blokhina S., Sharapova A., Ol'khovich M., Churakov, A., Perlovich G. New diclofenac choline hydrate salt: Synthesis, characterization and solubility. Journal of Molecular Structure, 2019, 1198, in press. (quartile 3; IF = 2.12; DOI: 10.1016/j.molstruc.2019.126922)
2. Drozd K.V., Manin A.N., Perlovich G.L. Comparative analysis of experimental methods for determining thermodynamic parameters of formation of multi-component molecular crystals: Benefits and limitations. J. Mol. Liq. 2019, in press (quartile 1; IF = 4.561; DOI: 10.1016/j.molliq.2019.111644)
3. Manin A.N., Voronin A.P., Drozd K.V., Perlovich G.L. Thermodynamic properties of Nalidixic and Oxolinic acids: Experimental and computational study. Thermochimica Acta, 2019, in press (quartile 2; IF = 2.251; DOI: 10.1016/j.tca.2019.178411)
4. Blokhina S., Sharapova A., Ol'khovich M., Perlovich G. Thermodynamic study of aceclofenac solubility, distribution and sublimation. J. Chem. Thermodyn. 2019, 137, 13–21. (quartile 1; IF = 2.29; DOI: 10.1016/j.jct.2019.05.014)
5. Sharapova A., Ol'khovich M., Blokhina S., Perlovich G. Solubility and vapor pressure data of bioactive 6-(acetylamino)-N-(5-ethyl-1,3,4-thiadiazol-2-yl) hexanamide. J. Chem. Thermodyn. 2019, 135, 35–44. (quartile 1; IF = 2.29; DOI: 10.1016/j.jct.2019.03.015)
6. Blokhina S., Sharapova A., Ol'khovich M., Perlovich G. A thermodynamic study of sublimation, dissolution and distribution processes of anti-inflammatory drug Clonixin. J. Chem. Thermodyn. 2019, 132, 281–288. (quartile 1; IF = 2.29; DOI: 10.1016/j.jct.2019.01.006)
7. Surov A.O., Vasilev N.A., Churakov A.V., Stroh J., Emmerling F., Perlovich G.L. Solid Forms of Ciprofloxacin Salicylate: Polymorphism, Formation Pathways, and Thermodynamic Stability. Crystal Growth & Design, 2019, 19(5), 2979-2990. (quartile 1; IF = 4.153; DOI: 10.1021/acs.cgd.9b00185)
8. Surov A.O., Manin A.N., Voronin A.P., Boycov, D.E., Magdysyuk, O.V., Perlovich, G.L. New Pharmaceutical Cocrystal Forms of Flurbiprofen: Structural, Physicochemical, and Thermodynamic Characterization. Crystal Growth & Design, 2019, 19, 5751-5761. (quartile 1; IF = 4.153; DOI: 10.1021/acs.cgd.9b00781)
9. Dai X.-L., Voronin A.P., Gao W., Perlovich G.L., Lu T.-B., Chen J.-M. Intermolecular interactions and permeability of 5-fluorouracil cocrystals with a series of isomeric hydroxybenzoic acids: A combined theoretical and experimental study. CrystEngComm, 2019, 21(34), 5095-5105. (quartile 1; IF = 3.382; http://dx.doi.org/10.1039/c9ce00661c)
10. Tao Q., Hao Q.-Q., Voronin A.P., Dai X.-L., Huang Y., Perlovich G.L., Lu T.-B., Chen J.-M. Polymorphic Forms of a Molecular Salt of Phenazopyridine with 3,5-Dihydroxybenzoic Acid: Crystal Structures, Theoretical Calculations, Thermodynamic Stability, and Solubility Aspects. Crystal Growth & Design, 2019, 19, 5636-5647. (quartile 1; IF = 4.153; DOI: 10.1021/acs.cgd.9b00618)
11. Perissinotti L.,  Guo J., Kudaibergenova M.,  Lees-Miller J., Ol’khovich M.,  Sharapova A., Perlovich G.L.,Muruve D.A., Gerull B., Noskov S.Yu., Duff H.J. The Pore-Lipid Interface: Role of Amino Acid Determinants of Lipophilic Access by Ivabradine to the hERG1 Pore Domain. Molecular Pharmacology, 2019, 96 (2), 259-271. (quartile 1; IF = 2.78; DOI: 10.1124/mol.118.115642)
12. Manin A.N., Drozd K.V., Churakov A.V., Perlovich G.L. Design of 4-aminobenzoic acid two-component molecular crystals: prediction and experiments. CrystEngComm, 2019, 21(13), 2119-2129. (quartile 1; IF = 3.304; http://dx.doi.org/10.1039/C8CE01857J)
13. Ol'khovich M.V., Sharapova A.V., Blokhina S.V., Perlovich G.L., Skachilova S.Y., Shilova, E. A study of the inclusion complex of bioactive thiadiazole derivative with 2-hydroxypropyl-β-cyclodextrin: preparation, characterization and physicochemical properties. J. Mol. Liq. 2019, 273, 653-662. (quartile 1; IF = 4.561; DOI: 10.1016/j.molliq.2018.10.053)
14. Blokhina S.V., Sharapova A.V., Ol'khovich M.V., Proshin A.N., Perlovich G.L. Distribution behavior of potential bioactive 1-azabicyclo[3,3,1]nonane derivatives in some organic solvent/buffer pH 7.4 systems. J. Chem. Thermodyn. 2018, 121, 211–221. (quartile 1; IF = 2.631; DOI: 10.1016/j.jct.2018.02.023)
15. Manin, A.N., Drozd, K.V., Churakov, A.V., Perlovich, G.L. Hydrogen Bond Donor/Acceptor Ratios of the Coformers: Do They Really Matter for the Prediction of Molecular Packing in Cocrystals? the Case of Benzamide Derivatives with Dicarboxylic Acids. Cryst. Growth Des., 2018, 18(9), 5254-5269. (quartile 1; IF = 3.972; DOI: 10.1021/acs.cgd.8b00711)
16. Drozd, K.V.; Arkhipov, S.G.; Boldyreva, E.V.; Perlovich, G.L. Crystal structure of a 1:1 salt of 4-aminobenzoic acid (vitamin B10) with pyrazinoic acid. Acta Cryst., 2018, E74, 1923-1927. (quartile 1; IF = 0.347; DOI: 10.1107/S2056989018016663)
17. Surov A.O., Voronin A.P., Vener M.V., Churakov A.V., Perlovich G.L. Specific features of supramolecular organisation and hydrogen bonding in proline cocrystals: a case study of fenamates and diclofenac. CrystEngComm, 2018, 20, 6970-6981. (quartile 1; IF = 3.304; doi: 10.1039/c8ce01458b)
18. Blokhina S.V., Sharapova A.V., Ol’khovich M.V., Ustinov A., Perlovich G.L. New derivatives of hydrogenated pyrido[4,3-b]indoles as potential neuroprotectors: Synthesis, biological testing and solubility in pharmaceutically relevant solvents. Saudi Pharmaceutical Journal, 2018, 26, 801–809. (quartile 1; IF = 3.11; doi.org/10.1016/j.jsps.2018.04.003)
19. Perlovich G.L., Volkova T.V. Sublimation thermodynamic aspects of adamantane and memantine derivatives of sulfonamide molecular crystals. Phys. Chem. Chem. Phys., 2018, 20, 19784 – 19791. (quartile 1; IF = 3.906; http://dx.doi.org/10.1039/C8CP03716G)
20. Manin A.N., Voronin A.P., Drozd K.V., Churakov A.V., Perlovich G.L. Pharmaceutical salts of emoxypine with dicarboxylic acids. Acta Cryst. 2018 C74, 797-806. (quartile 1; IF = 8.678 (2018); https://doi.org/10.1107/S2053229618007386)
21. Perlovich G.L. Two-component molecular crystals: Relationship between the entropy term and the molecular volume of co-crystal formation. CrystEngComm, 2018, 20, 3634 - 3637. (quartile 1; IF = 3.304; http://dx.doi.org/10.1039/C8CE00592C)
22. Voronin A.P., Volkova T.V., Ilyukhin A.B., Trofimova T.P., Perlovich G.L. Structural and Energetic aspects of Adamantane and Memantine Derivatives of Sulfonamide Molecular Crystals: Experimental and Theoretical Characterisation. CrystEngComm, 2018, 20, 3476–3489. (quartile 1; IF = 3.304; http://dx.doi.org/10.1039/c8ce00426a)
23. Surov A.O., Churakov A.V., Proshin A.N., Dai X.-L., Lu T., Perlovich G.L. Cocrystals of 1,2,4-thiadiazole-based potent neuroprotector with gallic acid: solubility, thermodynamic stability relationships and formation pathways. Phys. Chem. Chem. Phys., 2018, 20, 14469 – 14481. (quartile 1; IF = 3.906; http://dx.doi.org/10.1039/C8CP02532K)
24. Surov A.O., Voronin A.P., Drozd K.V., Churakov A.V., Roussel P., Perlovich G.L. Diversity of crystal structures and physicochemical properties of ciprofloxacin and norfloxacin salts with fumaric acid. CrystEngComm, 2018, 20, 755–767. (quartile 1; IF = 3.304; http://dx.doi.org/10.1039/c7ce02033c)
25. Blokhina S.V., Ol’khovich M.V., Sharapova A.V., Volkova T.V., Proshin A.N., Perlovich G.L. Solubility and distribution of bicycle derivatives of 1,3-selenazine in pharmaceutically relevant media by saturation shake-flask method. J. Chem. Thermodynamics, 2017, 115, 285-292. (quartile 1; IF = 2.726; http://dx.doi.org/10.1016/j.jct.2017.08.012)
26. Blokhina S.V., Sharapova A.V., Ol’khovich M.V., Volkova T.V., Proshin A.N., Perlovich G.L. Thermodynamic aspects of solubility and solvation of bioactive bicyclic derivatives in organic solvents. J. Chem. Eng. Data, 2017, 62(12), 4288-4295. (quartile 1; IF = 2.323; DOI: 10.1021/acs.jced.7b00641)
27. Blokhina S.V., Volkova T.V., Golubev V.A., Perlovich G.L. Understanding of Relationship between Phospholipid Membrane Permeability and Self-Diffusion Coefficients of Some Drugs and Biologically Active Compounds in Model Solvents. Mol. Pharm. 2017, 14, 3381-3390. (quartile 1; IF = 4.440; DOI: 10.1021/acs.molpharmaceut.7b00401)
28. Blokhina S.V., Sharapova A.V., Ol’khovich M.V., Volkova T.V., Perlovich G.L., Proshin A.N. Sublimation enthalpy of 1,3-thiazine structural analogues: Experimental determination and estimation based on structural clusterization. Thermochimica Acta, 2017, 656, 10-15. (quartile 2; IF = 2.236; DOI: 10.1016/j.tca.2017.08.004)
29. Blokhina S.V., Sharapova A.V., Ol’khovich M.V., Perlovich G.L. Sublimation thermodynamics of four fluoroqunolone antimicrobial compounds. J. Chem. Thermodynamics, 2017, 105, 37-43. (quartile 1; IF = 2.726; http://dx.doi.org/10.1016/j.jct.2016.10.010)
30. Perlovich G.L. Prediction of Sublimation Functions of Molecular Crystals Based on Melting Points: Cocrystal Formation Thermodynamics Application. Cryst. Growth Des. 2017, 17 (8), p. 4110–4117. (quartile 1; IF = 4.055; DOI: 10.1021/acs.cgd.7b00290)
31. Perlovich G.L. Two-component molecular crystals: evaluation of the formation thermodynamics based on melting points and sublimation data. CrystEngComm 2017, 19, 2870 –2883. (quartile 1; IF = 3.474; DOI: 10.1039/c7ce00554g)
32. Ol'khovich M.V., Sharapova A.V., Perlovich G.L., Skachilova S.Y., Zheltukhin N.K. Inclusion complex of antiasthmatic compound with 2-hydroxypropyl-β-cyclodextrin: Preparation and physicochemical properties. Journal of Molecular Liquids, 2017, 237, 185-192. (quartile 1; IF = 3.648; DOI: 10.1016/j.molliq.2017.04.098)
33. Ol'khovich M.V., Sharapova A.V., Skachilova S.Y., Perlovich G.L. Physico-chemical study of bioactive N-(5-ethyl-1,3,4-thiadiazole-2-yl)-4-nitrobenzamide: Sublimation, solubility and distribution. Thermochimica Acta, 2017, 657, 72-78. (quartile 2; IF = 2.236; http://dx.doi.org/10.1016/j.tca.2017.09.010)
34. Drozd K.V., Manin A.N., Churakov A.V., Perlovich G.L. Drug-Drug Cocrystals of Antituberculous 4-Aminosalicylic Acid: Screening, Crystal Structures, Thermochemical and Solubility Studies. European Journal of Pharmaceutical Sciences 2017, 99, 228-239. (quartile 1; IF = 3.753; http://dx.doi.org/10.1016/j.ejps.2016.12.016)
35. Drozd K.V., Manin A.N., Churakov A.V., Perlovich G.L. Novel drug–drug cocrystals of carbamazepine with para-aminosalicylic acid: screening, crystal structures and comparative study of carbamazepine cocrystal formation thermodynamics. CrystEngComm 2017, 19, 4273 –4286. (quartile 1; IF = 3.474; DOI: 10.1039/c7ce00831g)
36. Surov A.O., Volkova T.V., Churakov A.V., Proshin A.N., Terekhova I.V., Perlovich G.L. Cocrystal formation, crystal structure, solubility and permeability studies for novel 1,2,4-thiadiazole derivative as a potent neuroprotector. European Journal of Pharmaceutical Sciences 2017, 109(15), 31-39. (quartile 1; IF = 3.753; http://dx.doi.org/10.1016/j.ejps.2017.07.025)
37. Surov A.O., Manin A.N., Voronin A.P., Churakov A.V., Perlovich G.L., Vener M.V. Weak Interactions Cause Packing Polymorphism in Pharmaceutical Two-Component Crystals. The Case Study of the Salicylamide Cocrystal. Cryst. Growth Des. 2017, 17(3), 1425−1437. (quartile 1; IF = 4.055; DOI: 10.1021/acs.cgd.7b00019)
38. Chislov M.V., Silyukov O.I., Kumeev R.S., Proshin A.N., Perlovich G.L., Terekhova I.V. Complex formation of cyclodextrins with some pharmacologically active 1,2,4-thiadiazole derivatives. J. Therm. Anal. Calorim. 2017, 127, 1797–1805. (quartile 2; IF = 2.1; DOI: 10.1007/s10973-016-5929-1)
39. Ol’khovich M.V., Sharapova A.V., Blokhina S.V., Perlovich G.L. Sulfasalazine: dissolution and distribution in pharmaceutically relevant mediums. J. Chem. Eng. Data 2017, 62(1), 123–128. (quartile 1; IF = 2.323; DOI: 10.1021/acs.jced.6b00497)
40. Sharapova A.V., Ol’khovich M.V., Blokhina S.V., Perlovich G.L. Physico-chemical characterization antituberculosis thioacetazone: Vapor pressure, solubility and lipophilicity. J. Chem. Thermodynamics, 2017, 108, 18-25. (quartile 1; IF = 2.726; DOI: 10.1016/j.jct.2016.12.034)
41. Volkova T.V., Terekhova I.V., Silyukov O.I., Proshin A.N., Bauer-Brandl A., Perlovich G.L. Towards the rational design of novel drugs based on solubility, partitioning/distribution, biomimetic permeability and biological activity exemplified by 1,2,4-thiadiazole derivatives. MedChemComm 2017, 8, 162-175. (quartile 1; IF = 2.31; DOI: 10.1039/c6md00545d)
42. Volkova T.V., Perlovich G.L., Terekhova I.V. Enhancement of dissolution behavior of antiarthritic drug leflunomide using solid dispersion methods. Thermochimica Acta, 2017, 656, 123-128. (quartile 2; IF = 2.236; http://dx.doi.org/10.1016/j.tca.2017.09.003)
43. Perlovich, G.L.; Surov A.O.; Manin, A.N. Chapter 2 “Pharmaceutical multi-component crystals with antituberculous application” (pp 32 – 59) // Tiekink, E. (Ed.) & Zukerman-Schpector, J. (Ed.) (2017). Multi-Component Crystals. Synthesis, Concepts, Function. Berlin, Boston: Walter de Gruyter GmbH. ISBN: 978-311046495-5;978-311046365-1. (DOI: 10.1515/9783110464955-002)
44. Perlovich G.L., Surov A.O. Chapter 10 “Fenamate Crystals and Cocrystals: Structural and Thermodynamic Aspects.” In book “Crystal Growth: Concepts, Mechanisms and Applications” By editors Prof. Jinjin Li. 2017. ISBN: 978-1-53612-226-8. NOVA SCIENCE PUBLISHERS, INC. NY, USA. p. 317-363.